Michael del Priore
Plus aucun poste en cours
Profil
Actuellement, Michael Del Priore occupe le poste de directeur de l'information chez Diversey Holdings Ltd. (îles Caïmans). Il a précédemment occupé les postes de directeur de l'information chez Church & Dwight Co. Inc., de directeur des systèmes d'information chez Philip Morris USA Inc., de directeur de l'information et de vice-président principal de Catalent Pharma Solutions Inc. et de vice-président des opérations informatiques commerciales mondiales chez Hoffmann-La Roche Inc. Il a obtenu un diplôme de premier cycle à l'Université d'État de New York et un MBA à l'Université Pace.
Anciens postes connus de Michael del Priore
| Sociétés | Poste | Fin |
|---|---|---|
| DIVERSEY HOLDINGS, LTD. | Chief Tech/Sci/R&D Officer | 05/07/2023 |
Philip Morris USA, Inc.
 Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Chief Tech/Sci/R&D Officer | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Chief Tech/Sci/R&D Officer | - |
| CHURCH & DWIGHT CO., INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Michael del Priore
| Pace University | Masters Business Admin |
| The State University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHURCH & DWIGHT CO., INC. | Consumer Non-Durables |
| Entreprise privées | 4 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Philip Morris USA, Inc.
Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Consumer Non-Durables |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Diversey Holdings Ltd. (Cayman Islands)
 Diversey Holdings Ltd. (Cayman Islands) Household/Personal CareConsumer Non-Durables Diversey Holdings Ltd. engages in the provision of hygiene, infection prevention, and cleaning solutions. It operates through the Institutional and Food and Beverage segments. The Institutional segment offers solutions to enhance cleanliness, safety, environmental sustainability, and efficiency for its customers. The Food and Beverage segment includes products to maximize the hygiene, safety, and efficiency of customer's production and cleaning processes while minimizing impact on the natural resources it consume. Its products and services include infection prevention, floor and building care chemicals, laundry, dosing and dispensing equipment, engineering and equipment solutions,, and water treatment. The company was founded on November 3, 2020, and is headquartered in Fort Mill, SC. | Consumer Non-Durables |
